149904-87-0

149904-87-0 structure

Name: CP 86325 sodium salt
Chemical Name: sodium,5-[[4-[3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propanoyl]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione
CAS Number: 149904-87-0
Molecular Formula: C₂₃H₁₉N₂NaO₄S
Molecular Weight: 442.46300
Catalog: Signaling Pathways Cell Cycle/DNA Damage PPAR
Create Date: 2016-07-13 05:16:29
Modify Date: 2025-08-27 15:01:19
Darglitazone Sodium, a thiazolidinedione, is an orally active, potent, and selective PPAR-γ (peroxisome proliferator-activated receptor) agonist. Darglitazone Sodium is effective in controlling blood glucose and lipid metabolism, and can be used for type II diabetes research[1][2].

Name	sodium,5-[[4-[3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propanoyl]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione
Synonyms	Darglitazone sodium salt DARGLITAZONE SODIUM UNII-A1P35HS4XI CP-86,325-2

Description	Darglitazone Sodium, a thiazolidinedione, is an orally active, potent, and selective PPAR-γ (peroxisome proliferator-activated receptor) agonist. Darglitazone Sodium is effective in controlling blood glucose and lipid metabolism, and can be used for type II diabetes research[1][2].
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> PPAR Research Areas >> Metabolic Disease Research Areas >> Neurological Disease
Target	PPAR-γ
References	[1]. Rashmi Kumari, et al. The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse. J Cereb Blood Flow Metab. 2010 Feb;30(2):352-60. [2]. Hoenig M, Ferguson DC. Effect of darglitazone on glucose clearance and lipid metabolism in obese cats. Am J Vet Res. 2003 Nov;64(11):1409-13.

RIDADR	NONH for all modes of transport